Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Elevated Expression of Maspin mRNA as a Predictor of Survival in Stage II and III Gallbladder Cancer Cases

  • Baghel, Kavita (Department of Surgical Gastroenterology, King George's Medical University) ;
  • Kazmi, Hasan Raza (Department of Surgical Gastroenterology, King George's Medical University) ;
  • Raj, Saloni (Department of Surgical Gastroenterology, King George's Medical University) ;
  • Chandra, Abhijit (Department of Surgical Gastroenterology, King George's Medical University) ;
  • Srivastava, Rajeshwar Nath (Department of Physical Medicine and Rehabilitation Center, King George's Medical University)
  • Published : 2014.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Maspin expression is a potential prognostic factor for various malignancies but its relation with gallbladder cancer is unknown and needs to be investigated needs to be investigated. We therefore here focused on maspin mRNA expression in normal, gall stone disease and gallbladder cancer subjects, with particular attention to prognostic importance in individuals with malignancies. Materials and Methods: This study was carried out at the Department of Surgical Gastroenterology, King George's Medical University, Lucknow, India. Gallbladder samples from normal (n=25), gall stone disease (n=25) and cancer patients (n=38) were analysed for maspin mRNA expression by semi-quantitative reverse transcriptase PCR and quantitative real time PCR. Statistical analysis was carried out using the Students t test or ANOVA. Survival analysis was conducted according to the Kaplan-Meier method and correlations were assessed using the Pearson correlation method. p<0.05 was considered statistically significant. Results: Significant increase (p=0.028) in expression of maspin mRNA was observed in gallbladder cancer as compared to gall stone disease, whereas no expression was found in normal tissues. Significant correlation (Pearson's coefficient(r)=-0.798, p<0.0001) was observed between relative quantification of maspin mRNA and survival of cancer patients after surgery, with significantly shorter (p=0.002) survival in patients having relative quantification >1.5 as compared to those having relative quantification <1.5. Similarly, significant differences in patient survival for maspin mRNA expression was observed for stage II (p=0.025) and III (p=0.011) cancer. Conclusions: Higher expression of maspin mRNA in gallbladder cancer has prognostic significance for stage II and III cancer, which needs to be investigated further.

Keywords

References

  1. Berardi R, Morgese F, Onofri A, et al (2013). Role of maspin in cancer. Clin Transl Med, 2, 8. https://doi.org/10.1186/2001-1326-2-8
  2. Chhabra D, Oda K, Jagannath P, et al (2012). Chronic heavy metal exposure and gallbladder cancer risk in India, a comparative study with Japan. Asian Pac J Cancer Prev, 13, 187-90. https://doi.org/10.7314/APJCP.2012.13.1.187
  3. Dhir V, Mohandas KM (1999). Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas. Indian J Gastroenterol, 18, 24-8.
  4. Diehl AK (1983). Gallstone size and the risk of gallbladder cancer. JAMA, 250, 2323-6. https://doi.org/10.1001/jama.1983.03340170049027
  5. Edge SB, Compton CC (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17, 1471-4. https://doi.org/10.1245/s10434-010-0985-4
  6. Gupta P, Agarwal A, Gupta V, et al (2012). Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res, 5, 41-7.
  7. Kazmi HR, Chandra A, Nigam J, et al (2013). Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder Cancer. Dig Surg, 30, 233-9. https://doi.org/10.1159/000353133
  8. Kim J, Jang KT, Kim KH, et al (2010). Aberrant maspin expression is involved in early carcinogenesis of gallbladder cancer. Tumour Biol, 31, 471-6. https://doi.org/10.1007/s13277-010-0056-2
  9. Kim JH, Kim HN, Lee KT, et al (2008). Gene expression profiles in gallbladder cancer: the close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis. Tumour Biol, 29, 41-9. https://doi.org/10.1159/000132570
  10. Kumar JR, Tewari M, Rai A, et al (2006). An objective assessment of demography of gallbladder cancer. J Surg Oncol, 93, 610-4. https://doi.org/10.1002/jso.20526
  11. Lowenfels AB, Walker AM, Althaus DP, Townsend G, Domellof L (1989). Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol, 18, 50-4. https://doi.org/10.1093/ije/18.1.50
  12. Maass N, Hojo T, Ueding M, et al (2001). Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res, 7, 812-7.
  13. Maesawa C, Ogasawara S, Yashima-Abo A, et al (2006). Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with Gall stone disease. J Clin Pathol, 59, 328-30. https://doi.org/10.1136/jcp.2005.027284
  14. Misra S, Chaturvedi A, Misra NC, Sharma ID (2003). Carcinoma of the gallbladder. Lancet Oncol, 4, 167-76. https://doi.org/10.1016/S1470-2045(03)01021-0
  15. Mohsin SK, Zhang M, Clark GM, Craig Allred D (2003). Maspin expression in invasive breast cancer: Association with other prognostic factors. J Pathol, 199, 432-35. https://doi.org/10.1002/path.1319
  16. Pandey M, Pathak AK, Gautam A, Aryya NC, Shukla VK (2001). Carcinoma of the Gallbladder. Dig Dis Sci, 46, 1145-51. https://doi.org/10.1023/A:1010652105532
  17. Randi G, Franceschi S, La Vecchia C (2006). Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer, 118, 1591-602. https://doi.org/10.1002/ijc.21683
  18. Shukla VK, Goel S, Trigun SK, Sharma D (2008). Electrophoretic pattern of proteins in carcinoma of the gallbladder. Eur J Cancer Prev, 17, 9-12. https://doi.org/10.1097/CEJ.0b013e3280145e1b
  19. Singh MK, Chetri K, Pandey UB, et al (2004). Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer. J Gastroenterol Hepatol, 19, 916-21. https://doi.org/10.1111/j.1440-1746.2004.03355.x
  20. Sood AK, Fletcher MS, Gruman LM, et al (2002). The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res, 8, 2924-32.
  21. Takanami I, Abiko T, Koizumi S (2008). Expression of maspin in non-small-cell lung cancer: correlation with clinical features. Clin Lung Cancer, 9, 361-6. https://doi.org/10.3816/CLC.2008.n.052
  22. Unisa S, Jagannath P, Dhir V, et al (2011). Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India. HPB (Oxford), 13, 117-25. https://doi.org/10.1111/j.1477-2574.2010.00255.x
  23. Volzke H, Baumeister SE, Alte D, et al (2005). Independent risk factors for gallstone formation in a region with high gall stone disease prevalence. Digestion, 71, 97-105. https://doi.org/10.1159/000084525
  24. Xia W, Lau YK, Hu MC, et al (2000). High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene, 19, 2398-403. https://doi.org/10.1038/sj.onc.1203535
  25. Wang Y, Sheng S, Zhang J, et al (2013). Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma. Plos One, 8, 63581. https://doi.org/10.1371/journal.pone.0063581
  26. Zou S, Zhang L (2000). Relative risk factors analysis of 3,922 cases of gallbladder cancer. Zhonghua Wai Ke Za Zhi, 38, 805-8.
  27. Zou Z, Anisowicz A, Hendrix MJC, et al (1994). Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science, 263, 526-9. https://doi.org/10.1126/science.8290962

Cited by

  1. Polymorphism and Expression Profile of Cholecystokinin Type A Receptor in Relation to Gallstone Disease Susceptibility vol.54, pp.5, 2016, https://doi.org/10.1007/s10528-016-9745-x
  2. Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancer pp.17437555, 2019, https://doi.org/10.1111/ajco.13129